The impact of a multidisciplinary, information technology supported program on blood pressure control in primary care

The impact of a multidisciplinary information technology-supported program on blood pressure control in primary care.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN75436659

Enrollment

500

Registered

2004-07-22

Start date

2004-05-01

Completion date

Unknown

Last updated

2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension Circulatory System Hypertension

Interventions

Intervention: We have developed an Information Technology (IT)-based system to help empower patients to be responsible for monitoring their Blood Pressure (BP) and compliance and to fa

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Male and female uncontrolled hypertensive subjects 2. 18 years of age or more

Exclusion criteria

Exclusion criteria: 1. Having a life-threatening disease 2. Chronic atrial fibrillation 3. Unable to use an ordinary telephone 4. Pregnant at the initial visit 5. Participating in another clinical trial 6. Living with another subject that is currently participating in the study

Design outcomes

Primary

Measure	Time frame
The primary objective of this study is to evaluate the impact of a multidisciplinary, information-technology supported hypertension management program on the mean change in 24-hour systolic and diastolic BP levels measured using Ambulatory Blood Pressure Monitoring (ABPM) compared to usual care.	—

Secondary

Measure	Time frame
1. To assess the likely mechanisms that account for the results for the primary objective by measuring refill compliance and the number and dosage of anti-hypertensive agents assessed through pharmacy prescription data records over the 12-month study period as well as the number and nature of interventions by pharmacists, nurses and physicians 2. To assess the effect of the program on mean daytime and nocturnal BP, office BP measured, the proportion of subjects who achieve target office BP 3. To assess the impact of the program on patient?s perceived health related quality of life 4. To assess the impact of the program on the incidence of adverse cardiovascular events, including hospitalisation for uncontrolled hypertension, new onset angina, myocardial infarction, hospitalisation for unstable angina, hospitalisation for congestive heart failure, hospitalisation for stroke, hospitalisation for other vascular event, and cardiovascular death 5. To evaluate the potential economic benefits of the intervention, from a third-party payer?s perspective	—

Measure

Time frame

1. To assess the likely mechanisms that account for the results for the primary objective by measuring refill compliance and the number and dosage of anti-hypertensive agents assessed through pharmacy prescription data records over the 12-month study period as well as the number and nature of interventions by pharmacists, nurses and physicians 2. To assess the effect of the program on mean daytime and nocturnal BP, office BP measured, the proportion of subjects who achieve target office BP 3. To assess the impact of the program on patient?s perceived health related quality of life 4. To assess the impact of the program on the incidence of adverse cardiovascular events, including hospitalisation for uncontrolled hypertension, new onset angina, myocardial infarction, hospitalisation for unstable angina, hospitalisation for congestive heart failure, hospitalisation for stroke, hospitalisation for other vascular event, and cardiovascular death 5. To evaluate the potential economic benefits of the intervention, from a third-party payer?s perspective

—

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026